Cargando…
(5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine
The title compound, C(13)H(14)N(2)OS, crystallizes as a racemate in a non-chiral space group. It represents a conformationally restricted analogue of so-called Biginelli compounds known to exhibit multiple pharmacological activities and was selected for a single-crystal X-ray analysis in order to pr...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971350/ https://www.ncbi.nlm.nih.gov/pubmed/21578538 http://dx.doi.org/10.1107/S1600536809044729 |
_version_ | 1782190606719647744 |
---|---|
author | Kettmann, Viktor Světlík, Jan Veizerová, Lucia |
author_facet | Kettmann, Viktor Světlík, Jan Veizerová, Lucia |
author_sort | Kettmann, Viktor |
collection | PubMed |
description | The title compound, C(13)H(14)N(2)OS, crystallizes as a racemate in a non-chiral space group. It represents a conformationally restricted analogue of so-called Biginelli compounds known to exhibit multiple pharmacological activities and was selected for a single-crystal X-ray analysis in order to probe the chemical and spatial requirements of some kinds of activity. It was found that the state of hybridization of the formally aminic nitrogen of the heterocycle is between sp (2) and sp (3) with the lone-pair electrons partially delocalized through conjugation with the sulfur atom rather than the double bond of the pyrimidine nucleus. As a result, the thiazolo ring adopts a flat-envelope conformation and the puckering of the central pyrimidine ring is close to a half-chair. The critical phenyl ring is fixed in a pseudo-axial and perpendicular [dihedral angle 84.6 (1)°] orientation with respect to the pyrimidine ring via an oxygen bridge. |
format | Text |
id | pubmed-2971350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-29713502010-12-30 (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine Kettmann, Viktor Světlík, Jan Veizerová, Lucia Acta Crystallogr Sect E Struct Rep Online Organic Papers The title compound, C(13)H(14)N(2)OS, crystallizes as a racemate in a non-chiral space group. It represents a conformationally restricted analogue of so-called Biginelli compounds known to exhibit multiple pharmacological activities and was selected for a single-crystal X-ray analysis in order to probe the chemical and spatial requirements of some kinds of activity. It was found that the state of hybridization of the formally aminic nitrogen of the heterocycle is between sp (2) and sp (3) with the lone-pair electrons partially delocalized through conjugation with the sulfur atom rather than the double bond of the pyrimidine nucleus. As a result, the thiazolo ring adopts a flat-envelope conformation and the puckering of the central pyrimidine ring is close to a half-chair. The critical phenyl ring is fixed in a pseudo-axial and perpendicular [dihedral angle 84.6 (1)°] orientation with respect to the pyrimidine ring via an oxygen bridge. International Union of Crystallography 2009-10-31 /pmc/articles/PMC2971350/ /pubmed/21578538 http://dx.doi.org/10.1107/S1600536809044729 Text en © Kettmann et al. 2009 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Organic Papers Kettmann, Viktor Světlík, Jan Veizerová, Lucia (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine |
title | (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine |
title_full | (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine |
title_fullStr | (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine |
title_full_unstemmed | (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine |
title_short | (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine |
title_sort | (5r*,11r*)-5-methyl-1,2-dihydro-5,11-methano-5h,11h-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine |
topic | Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971350/ https://www.ncbi.nlm.nih.gov/pubmed/21578538 http://dx.doi.org/10.1107/S1600536809044729 |
work_keys_str_mv | AT kettmannviktor 5r11r5methyl12dihydro511methano5h11h13thiazolo23d135benzoxadiazocine AT svetlikjan 5r11r5methyl12dihydro511methano5h11h13thiazolo23d135benzoxadiazocine AT veizerovalucia 5r11r5methyl12dihydro511methano5h11h13thiazolo23d135benzoxadiazocine |